THE CARDIOVASCULAR BENEFITS OF ANTI-OBESITY MEDICATIONS: A GAME-CHANGER IN HEART HEALTH

Dr. Imran Aslam, Dr. Muhammad Kalim Raza, Dr. Ayesha Ashraf, Dr. Vishal Chauhan

Research Focus · 2025-yil

Annotatsiya

Obesity is a significant global health challenge that increases the chance of developing cardiovascular disorders (CVDs), including heart failure, coronary artery disease, and hypertension. Traditional weight-loss methods often yield limited success, prompting the need for pharmacological interventions. Anti-obesity medications (AOMs) have emerged as effective tools for not only weight reduction but also improving cardiovascular health. This article explores the cardiovascular benefits of AOMs, including their role in lowering blood pressure, improving lipid profiles, reducing inflammation, and enhancing insulin sensitivity. Clinical trials, such as the SELECT and LEADER studies, provide strong evidence that medications like semaglutide, liraglutide, and tirzepatide significantly reduce major cardiovascular events. While AOMs offer promising heart health benefits, they should be integrated into a comprehensive lifestyle approach. This review highlights the transformative impact of anti-obesity medications in reducing cardiovascular risks and improving overall well-being.

Maqola ma’lumotlari
MualliflarDr. Imran Aslam, Dr. Muhammad Kalim Raza, Dr. Ayesha Ashraf, Dr. Vishal Chauhan
JurnalResearch Focus
Nashr sanasi2025-04-05
Jild4
Son3
Betlar149-154
TilIngliz

Kalit so‘zlar

Anti-obesity medications, cardiovascular health, obesity, weight loss, hypertension, lipid profile, insulin sensitivity, GLP-1 receptor agonists, cardiovascular disease prevention, metabolic health.

Ilmiy soha

Research Focus jurnalidan boshqa maqolalar

Research Focus — barcha maqolalar